CFRUY · Q2 2027 results

Compagnie Financiere Richemont SA Q2 2027 Earnings Recap

Published November 17, 2026 CFRUY -2.0% after the report

Richemont shares fell 2.0% after the results, a broadly muted reaction to strong first-half growth alongside a clear Q2 slowdown from Q1 and continued softness in Mainland China. Sales growth eased to 13% in Q2 from 20% in Q1, though it remained positive against a higher prior-year comparison.

The numbers

Reported results against what analysts expected.

Earnings per share $0.47 vs $0.42 expected · beat by 12.2%
Revenue 13543360000 vs 13942870000 expected · missed by 2.9%
Stock after the report -2.05% close to close around the results

Key takeaways

From the Q2 2027 earnings call.

  • First-half sales rose 16% to EUR 12.3 billion, or 17% at constant exchange rates; operating profit increased 33% to EUR 3.1 billion, including EUR 229 million of positive tariff-related one-time items. Excluding those items, operating profit was EUR 2.9 billion, versus EUR 2.4 billion a year earlier.
  • Jewellery Maisons sales grew 19% at constant exchange rates, Specialist Watchmakers delivered double-digit growth, and the other business area posted high single-digit growth.
  • Regional performance was broad-based: Americas sales rose 23%, Japan 30%, Europe 13% and Asia Pacific 16%. Middle East and Africa sales declined modestly amid ongoing conflict.
  • China, Hong Kong and Macau sales increased 7% for the half, but Mainland China remained persistently soft; Asia Pacific Q2 growth was 10%, down from 16% for the first half.
  • Operating cash flow reached EUR 2.5 billion and net cash was EUR 7.7 billion after a EUR 2.7 billion dividend payment.
Your portfolio

Track earnings for the stocks you own

Add your portfolio once, by connecting your broker or importing your history. When a company you hold reports, you get a recap like this one by email, with how the stock moved.

Also published on November 17, 2026

This summary was written by AI from the official earnings call transcript. It is for information only and is not financial advice. For CFRUY's price history and fundamentals, see the CFRUY stock page.